Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
Government Medical College · Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
248
total citations
- FWCI
- 23.79
- Percentile
- 100%
- References
- 9
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Medicine
- Placebo
- Tolerability
- Interim analysis
- Immunogenicity
- Population
- Interim
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.